Operating Income
Operating Income
Amgen Operating Income decreased by 2.0% to $2.67B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 126.3%, from $1.18B to $2.67B. Over 4 years (FY 2021 to FY 2025), Operating Income shows an upward trend with a 4.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Growth in operating income suggests that the core business is becoming more profitable and efficient.
Detailed definition
The profit realized from a business's own operations after deducting operating expenses like wages, depreciation, and co...
Peer comparison
This is a key metric for comparing the fundamental business performance of companies with different tax or debt structures.
Metric ID:
operating_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $828.00M | $2.38B | $2.30B | $2.50B | $2.18B | $2.66B | $2.23B | $1.92B | $2.68B | $2.02B | $1.27B | $991.00M | $1.91B | $2.05B | $2.31B | $1.18B | $2.66B | $2.53B | $2.72B | $2.67B |
| QoQ Change | — | +187.2% | -3.1% | +8.5% | -13.0% | +22.2% | -16.2% | -13.9% | +39.7% | -24.7% | -37.1% | -22.0% | +92.6% | +7.2% | +12.9% | -49.0% | +125.5% | -4.9% | +7.7% | -2.0% |
| YoY Change | — | — | — | — | +162.8% | +11.9% | -3.2% | -23.2% | +23.3% | -24.0% | -43.0% | -48.4% | -28.9% | +1.3% | +81.8% | +18.9% | +39.1% | +23.4% | +17.7% | +126.3% |
Range$828.00M – $2.72B
CAGR+27.9%
Avg YoY Growth+21.0%
Median YoY Growth+14.8%
Operating Income at Other Companies
Frequently Asked Questions
- What is Amgen's operating income?
- Amgen (AMGN) reported operating income of $2.67B in Q1 2026.
- How has Amgen's operating income changed year-over-year?
- Amgen's operating income increased by 126.3% year-over-year, from $1.18B to $2.67B.
- What is the long-term trend for Amgen's operating income?
- Over 4 years (2021 to 2025), Amgen's operating income has grown at a 4.4% compound annual growth rate (CAGR), from $7.64B to $9.08B.
- What does operating income mean?
- The profit earned from core business activities, before accounting for interest and taxes.